AI Assistant
Blog
Pricing
Log In
Sign Up
207 Claudin18.2-targeting CAB-T cells have superior safety over traditional CAR-T, while maintaining potent
in vivo
anti-tumor efficacy
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
